June 15, 2009
 

Giving Medication to Children


Giving Medication to Children
The director of FDA's Office of Pediatric Therapeutics discusses what parents should know about medication use in children.
Source: www.fda.gov

Recalls and Safety Alerts: Raptiva Withdrawn from the Market
Genentech is conducting a phased market withdrawal of the psoriasis drug Raptiva (efalizumab). The company is doing this because taking the drug carries the risk of developing progressive multifocal leukoencephalopathy (PML). PML, which is caused by...
Source: www.accessdata.fda.gov

Warning on Hydroxycut Products
FDA is warning consumers to stop using Hydroxycut products because of serious health risks. One death due to liver failure has been reported to the agency.
Source: www.fda.gov

FDA Promotes Openness and Transparency to Public
FDA is working to make useful information about FDA activities and decision making more readily available to the public.
Source: www.fda.gov

Subscribe to Posts [Atom]